反応式
[C:1]1([O:7][C:8](=[O:22])[NH:9][C:10]2[S:11][C:12]3[CH:18]=[C:17]([S:19][C:20]#[N:21])[CH:16]=[CH:15][C:13]=3[N:14]=2)[CH:6]=CC=CC=1.[N:23]1(CCN)[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1>>[N:23]1([CH2:6][CH2:1][O:7][C:8](=[O:22])[NH:9][C:10]2[S:11][C:12]3[CH:18]=[C:17]([S:19][C:20]#[N:21])[CH:16]=[CH:15][C:13]=3[N:14]=2)[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1参加物
3
実験手順
The 2-morpholin-4-ylethyl(6-thiocyanato-1,3-benzothiazol-2-yl)carbamate was prepared according to the method described in Example 9c, but using 654 mg of phenyl(6-thiocyanato-1,3-benzothiazol-2-yl)carbamate and 0.27 cm3 of 2-morpholin-4-ylethanamine. The residue obtained is chromatographed on an Analogix cartridge of 40 g of silica 15-40 μm, elution being carried out with a gradient of dichloromethane then 95/5 dichloromethane/methanol. 729 mg of 2-morpholin-4-ylethyl(6-thiocyanato-1,3-benzothiazol-2-yl)carbamate are thus obtained in the form of a white solid, the characteristics of which are as follows:
後処理
- customThe 2-morpholin-4-ylethyl(6-thiocyanato-1,3-benzothiazol-2-yl)carbamate was prepared
- customThe residue obtained
- customis chromatographed on an Analogix cartridge of 40 g of silica 15-40 μm, elution
出典と根拠
- ORDレコード
- ord-8530d4e82cc142dc83fe56336bfd36b3
- 出典データセット
- uspto-grants-2013_10
- 特許番号
- US08546393B2
関連ノート
読み込み中…